potassium phosphate 15 mmole added to 0.9% sodium chloride 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6060-1.
Published May 31, 2023 · Recall initiated: April 28, 2023
Summary
FDA records drug Class II recall D-0716-2023, published May 31, 2023 and initiated April 28, 2023. Recalling firm: Central Admixture Pharmacy Services, Inc.; Status: Terminated; Reported quantity: 9432 bags; Lot: Lot # 37-883769, Exp 05/02/2023; 37-884449, Exp 05/04/2023; 37-885585, Exp 05/09/2023; 37-885922, Exp 05/10/2023; 37-886526, Exp 05/14/2023; 37-887387, Exp 05/16/2023; 37-887659, 37-887662, Exp 05/17/2023; 37-889064, Exp 05/23/2023; 37-889735, 37-889745, Exp 05/25/2023; 37-890036, 37-890055, Exp 05/28/2023; 37-890934, Exp 05/30/2023; 37-892890, Exp 06/07/2023; 37-893813, Exp 06/12/2023; 37-894317, Exp 06/13/2023; 37-895275, Exp 06/18/2023; 37-896822, 37-896852, Exp 06/22/2023; 37-897826, 37-897839, Exp 06/27/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Distributor
- Nationwide in the USA.
- Lot
- Lot # 37-883769, Exp 05/02/2023; 37-884449, Exp 05/04/2023; 37-885585, Exp 05/09/2023; 37-885922, Exp 05/10/2023; 37-886526, Exp 05/14/2023; 37-887387, Exp 05/16/2023; 37-887659, 37-887662, Exp 05/17/2023; 37-889064, Exp 05/23/2023; 37-889735, 37-889745, Exp 05/25/2023; 37-890036, 37-890055, Exp 05/28/2023; 37-890934, Exp 05/30/2023; 37-892890, Exp 06/07/2023; 37-893813, Exp 06/12/2023; 37-894317, Exp 06/13/2023; 37-895275, Exp 06/18/2023; 37-896822, 37-896852, Exp 06/22/2023; 37-897826, 37-897839, Exp 06/27/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATotal Parental Nutrition - Pediatric PN Patient-Specific TPN Bag, (patient specific), Rx#July 1, 2026
- FDAPHENYLephrine added to 0.9% sodium chloride, 40 mg/250 mL* (160 mcg/mL), Rx Only, CAPS, Central AdmixtureMarch 19, 2025
- FDANeonatal TPN Starter Bag, Amino Acids (trophamine) 3.5%/Dextrose 10% with HEPARIN, IV Bag, total volume =September 6, 2023
- FDAEPINEPHrine added to dextrose 5%, 4mg/250ml (16 mcg/mL), IV Bag, Rx Only, Central Admixture Pharmacy Services,September 6, 2023
- FDAPHENYLephrine added to 0.9% sodium chloride, 10 mg/250 mL* (40 mcg/mL), 250 mL per bag, Rx only, CentralMay 31, 2023
- FDAvancomycin added to 0.9% sodium chloride, 1 g/250 mL* (4 mg/mL), 25 250 mL per bag, Rx only, Central AdmixtureMay 31, 2023
Questions about this recall
Was potassium phosphate 15 mmole added to 0.9% sodium chloride 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6060-1. recalled?
Yes. FDA published recall D-0716-2023 on May 31, 2023. Reported hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail